SlideShare une entreprise Scribd logo
1  sur  7
Télécharger pour lire hors ligne
IBC
LIFE SCIENCES
Produced by:
International Marketing Partner:
Media Partners:
26-29
AUGUST 2014
S i n g a p o r e
Featuring Expert Insights
Part of:
Why You Must Attend
Hear from 25+ R&D Expert Speakers
Gain Insights on Licensing, M&A, Regulations
and More!
R&D Investment and Funding Opportunities
from Leading Venture Capitalists
Craft IP Strategies and Ensure Formula
Confidentiality in the Asian region
New Interactive and In-Depth Formats: Panel
Discussions, Roundtable Discussions, VIP
Lunch Tables
Jun Bao
Senior Vice President &
Chief Business Officer,
Shenogen Pharma
Group, China
Joe Zhang
Executive Deputy Head,
Center of Medical and
Translational Sciences,
Shanghai CP Guojian
Pharmaceutical, China
Kantharaj Ethirajulu
Head,Research&Development,
Technical- Drug Discovery &
Development,
The Biomedical Sciences
Institute (BMSI), Singapore
Ben Ni
Head & Senior Director,
Partnering & External
Innovation,
Sanofi R&D, China
Dr. Narendra Vutla
Executive Vice President &
Head of R&D-Wellness, Oral
Health & Site Operations,
GSK Consumer Healthcare,
India
P A R K R O Y A L
on Beach Road
Pre- Conference Special Focus Day
26 August 2014 • 9am – 5pm
Clinical Trial Development in Asia
Post Conference Workshop
29 August 2014 • 9am – 5pm
China R&D
www.pharmaconasia.com
Peter W. Tsao
Vice President Business
Development,
TaiGen Biotechnology,
Taiwan
Supported by:
Sponsors:
Life
Sciences
8:00 Registration Opens & Morning Coffee
8:50 Welcome from IBC Asia & Morning Ice Breaker
9:00 Chairperson’s Opening Remarks
Asia’s Pharmaceutical Market Outlook & Regulatory Updates
9:10 Asia Pharmaceutical Investment Opportunities &
Development
• Where is the Asian pharmaceutical market heading towards?
• What are the investment and market opportunities available in
Asia?
• How are pharma companies in Asia coping with intensifying
competition and investment from overseas?
• Selecting the best business model, communication and operations
to maximize market share in Asia
• How regional integration has affected product launch and
marketing in the prescription and non-prescription market
Jun Bao, Senior Vice President & Chief Business Officer,
Shenogen Pharma Group, China
Billy Sarvanantham Urudr, Chief Commercial Officer,
CCM Pharmaceuticals Sdn Bhd, Malaysia
Dr. Narendra Vutla, Executive Vice President & Head of R&D –
Wellness, Oral Health & Site Operations, GSK Consumer
Healthcare, India
Carl Firth, CEO, Asia Pharmaceuticals, Singapore
10:00 Asia’s Evolving Regulatory Landscape & Development
• Current initiatives and regulatory trends in Southeast Asia
• International models, frameworks and standards for Asia to adopt
• Regulatory trends and their impact on R&D investment
• Recent pharma marketing regulations changes, expected new
guidelines and compliance process under AEC
• Are pharma companies ready for the implementation and the
liberalization of health care services?
• Current regulatory challenges faced and how they can be tackled
• ASEAN harmonization and to what extent will it drive Asian
innovation?
Joy Chen, Director, Regulatory Affairs, Reckitt Benckiser,
Singapore
ArielValencia, DeputyDirector, Food & Drug Administration,
Philippines
Koichi Miyazaki, Senior Director, Regulatory Affairs Group, Asia
Development Department, Daiichi Sankyo, Japan
10:40 Morning Networking & Refreshment Break
Financing, Partnerships & Collaboration
11.25 Chairperson’s Opening Remarks
Jun Bao, Senior Vice President & Chief Business Officer,
Shenogen Pharma Group, China
11.30 Strategic Partnerships & Collaboration as a Key to Driving
Asian Drug Innovation
• Introduction to a multi collaboration and partnership model to
drive innovation
• Getting the best out of your partnerships
• Approaches to incorporate partnerships into your R&D model
Ben Ni, Head&SeniorDirector,Partnering&ExternalInnovation,
Sanofi R&D, China
12.10 Strategic Licensing, Mergers & Acquisitions Trends for
Pharma R&D Development
• Evaluating recent licensing and M&A trends in Asia
• What do these trends signify?
• Different licensing trends for large and small companies, its
challenges and how they can be tackled
• Where is the Asian pharmaceutical market headed to?
Yariv Hefez, Vice President Business Development, Portfolio
Management, Strategy and Partnering, Biosimilars Unit,
Merck Serono, Switzerland
Peter W. Tsao, Vice President Business Development,
TaiGen Biotechnology, Taiwan
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
27
CONFERENCE DAY ONE
AUGUST 2014 | Wednesday
VISIONARYKEYNOTE
12:50 Speed Networking
13:00 Networking Lunch
Have a chance to have an informal chat withVIP guests during
the networking lunch break
VIP 1: Yuan Hua Ding, Senior Director & Head of External R&D
Innovation – Asia, Pfizer Worldwide Research &
Development, Pfizer, USA
VIP 2: Ben Ni, Head & Senior Director, Partnering & External
Innovation, Sanofi R&D, China
14:00 Venture Capital Opportunities for Drug Discovery &
Development in Asia
• Funding models and investment opportunities in Asia
• Latest innovations and fields that are gathering interests among
venture capitalists
• What constitutes a good business model and presentation
• Collaboration opportunities with venture capitalists
• Key criteria for investment
Goro Takeda, Venture Partner, Sofinnova Ventures, Japan
Jun Wu, Chairman & Managing Director, Cenova Ventures,
China
Jason Mann, ManagingDirector, Fenex Capital Management,
China
14:40 Discovery Outsourcing to Asia: Lessons Learnt
• What are the challenges faced by a global western company when
outsourcing to Asia?
• Key concerns from the West
• What approach was taken when tackling the challenges faced in
Asia?
15:10 Afternoon Networking & Refreshment Break
Clinical Trial Development in Asia
15:50 Managing Risks in Clinical Outsourcing to Southeast Asia
• Understanding regulations, clinical infrastructure and risks when
conducting clinical trials in Asia
• Handling ethnicity and cultural differences within Southeast Asia:
What are the differences and similarities in risks?
• Strategies to minimize and manage these risks
• EstablishingstandardsandIPprotectioninclinicaltrialsinSoutheast
Asia
16:30 Developing Clinical Trials in Oncology in Singapore
• Difficulties faced in conducting oncology clinical research and
how were they tackled
• Advice in clinical trials design for oncology in Singapore
• Tackling oncology clinical trials unique risks and managing them
• Ways to carry out the trials efficiently without compromising on
quality and safety
Joanne Chio, Head, Clinical Trials, Haematology-Oncology
Research Group, National University Cancer Institute (NCIS),
National University Hospital, Singapore
Intellectual Property Rights
17:00 IP Trends & Patent Strategies
• Insight into compulsory licensing in India and Indonesia
• Viewpoint of the compulsory licensing system in Asia
• Singapore’s patent linking system for generics
• What are the common issues in intellectual property and how can
they be addressed?
• Laws protecting and ensuring confidentiality when conducting
research in Asia
Debolina Partap, Associate Vice President & Head of Legal,
Wockhardt Group, India
SohKarLiang, ManagingDirector, EllaCheongLLC, Singapore
Manh Hung Tran, Principal & Managing Lawyer, BMVN
International LLC, a member of Baker & McKenzie
International, Vietnam
17:40 Chairperson’s Summary of the Day &
End of Conference Day One
PANELDISCUSSION
PANELDISCUSSIONPANELDISCUSSION
PANELDISCUSSION
8:30 Morning Networking & Coffee
9:00 Chairperson’s Opening Remarks
Kantharaj Ethirajulu, Head,Research&Development,Technical
– Drug Discovery & Development, The Biomedical Sciences
Institute (BMSI), Singapore
Generics & Biosimilars R&D in Asia
9:10 Biosimilars & Generics R&D in Asia – What Can We Do To
Maintain the Lead?
• Overview of the generics and biosimilars industry in Asia
• A review of science and technology developments for making
complex generic drugs
• Strategies in retaining Asia’s stronghold in follow-on drug R&D to
ensure Return On Investment (ROI) in sales
• If not follow-on drugs, what’s next?
Moderator
Gene Ching-Hung Hsu, Senior Vice President, HEC Pharm
Group, China
Panelists
Kasibhatta Ravisekhar, Vice President, Clinical Research,
Lupin Pharmaceuticals, India
Qiang Lu, Chief Scientific Officer, Yangtze River
Pharmaceutical Group, China
Joe Zhang, Executive Deputy Head, Center of Medical and
TranslationalSciences, Shanghai CP Guojian Pharmaceutical,
China
9:50 Morning Networking & Refreshment Break
Driving Drug Innovation in R&D
10:20 Biomedical Innovation & Pharmaceutical Growth
• How is pharmaceutical growth in Asia fueling biomedical
innovation in the region?
• Potential and current growth areas of focus in Asian biomedical
innovation
• Challenges Asia is facing that could limit its growth potential and
what can be done
Yuan Hua Ding, Senior Director & Head of External R&D
Innovation – Asia, Pfizer Worldwide Research &
Development, USA
11:00 Challenges in Drug Discovery & Development in Asia
• Challenges faced in Asia and how to tackle them
• Overcoming lack of fundamental knowledge for drug discovery
• Streamlining drug development process for efficiency
• Drug candidates discovered and developed in Asia
Kantharaj Ethirajulu, Head,Research&Development,Technical
– Drug Discovery and Development, The Biomedical Sciences
Institute (BMSI), Singapore
Scientific Advances Showcase
11:40 Aggregation in Biosimilars: Orthogonal Analytical Tools
in Assessment of Monoclonal Antibodies
• Developing analytical methods to study structural change in
biosimilar monoclonal antibodies
• Eliminating structural change due to change in process conditions
• Minimizing structural modifications without compromising on
potency of drug
Dr. Kalyan Sundaram, Senior Research Scientist, Lupin, India
12:20 Networking Lunch
13:40 Drug Discovery from Natural Medicines by Novel
Approaches
• Post-absorption/metabolism drugs (PAMD ) concept
• Discovery of active metabolite in ginseng which is currently in
phase III clinical trials for anti-depression
• Results of pharmacokinetics/pharmacodynamics (PK/PD) studies
of the metabolite and clinical trials
• Future work and initiatives in areas of natural products drug
discovery
William Jia, Chief Scientific Advisor, SAPHRONTM
Database
Service Centre, Shanghai Innovative Research Centre of
Traditional Chinese Medicine (SIRC/TCM), China
Infrastructure & Resource Development for R&D
14:20 Establishing R&D Infrastructure & Talent Resources
• Current status of clinical and R&D facilities infrastructure
• What are governments in the region doing to improve and promote
clinical and R&D development?
• Creating a quality and innovative facility in the Philippines: What
is required?
• Current R&D talent pool outlook in the Philippines
• What can be done to further develop, attract and retain R&D talent?
Rodel Sibulo, Director of R&D, Pascual Laboratories,
Philippines
Technology Transfer in Drug Discovery R&D
15:00 Ensuring Reproducibility during Knowledge &Technology
Transfer in R&D Outsourcing
• Determining the right conditions for technology transfer
• Partnering and selecting the right organizations for collaboration
• Advice and methods in ensuring data quality and reproducibility
during knowledge transfer
• Getting the maximum benefits out of the collaboration
Qiang Lu, Chief Scientific Officer, Yangtze River
Pharmaceutical Group, China
15:40 Afternoon Networking & Refreshment Break
Interactive Round Table Sessions
16:20 Roundtable 1: Pharmacokinetics/pharmacodynamics
(PK/PD) Guided Clinical Research for Generics
Kasibhatta Ravisekhar, Vice President, Clinical Research,
Lupin Pharmaceuticals, India
____________________________________________________
Roundtable 2: Inhouse vs Outsourced R&D
Hwee Ching Ang , Head of Science Hub, Singapore Region
Global External Innovation & Alliances, Bayer Healthcare,
Singapore
____________________________________________________
Roundtable 3: R&D Strategies for an Innovative Pipeline
James Garner, Head, Unit Operations, Sanofi-Aventis,
Singapore
17:40 Chairperson’s Closing Remarks &
End of the Pharmaceutical R&D Conference
28
CONFERENCE DAY TWO
AUGUST 2014 | Thursday
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
NEWDATA
NEWDATAPANELDISCUSSION
POST-CONFERENCE WORKSHOP
29 AUGUST 2014, FRIDAY (0900 – 1700)
WORKSHOPS
8:30 Registration & Morning Coffee
8:50 Introduction
Naeem Noordin, Managing Director, Siara Pte Ltd,
Singapore
9:00 Session 1: Clinical Trial Requirements & Regulations
in Asia
• Insights into clinical trials requirements and regulations in Asia
Pacific
• Preparing for a regulatory inspection and tips on what the
regulators are looking for
• Crafting and submitting what is required in a clinical trial
application (CTA)
Christophe Tournerie, CEO, ClinActis, Singapore
10:30 Morning Networking & Refreshment Break
11:00 Improving & Ensuring the Quality of Clinical Trials
& Data
• Quality standards in clinical trials
• Strategies to ensure, monitor and improve clinical trials data
quality during outsourcing of clinical trials
• Creating a strategy to minimize risks for data integrity
Emily Tan, Vice President, Clinical Operations Asia Pacific,
inVentiv Health Clinical, Singapore
12:30 Networking Lunch Break
13:30 Clinical Site Management & Use of Site Management
Organizations (SMO)
• Selection and evaluation of a clinical trial site
• Integration of a quality system, SOPs and training to ensure
quality trial data in different clinical sites
• Employing a risk based management to ensure clinical quality
at site
• Use of site management organization (SMO)
Shashi Adsul, Head of Clinical Operations, South East Asia,
Boehringer-Ingelheim, Singapore
14:30 Application of Digital Technologies for Patient
Recruitment & Retention
• Utilizing digital technologies for a patient centric and efficient
patient recruitment procedure
• Cutting costs and time through digital recruitment
• Case studies and applications
Ramita Tandon, Senior Vice President & General Manager,
inVentiv Health ClinicalTrial Recruitment Solutions, USA
15:30 Afternoon Networking & Refreshment Break
16:00 Informed Consent in Clinical Trials
• Informed consent implementation process, guidelines and the
people involved
• Systematic development of the informed consent form
• Cultural issues and challenges to be taken into consideration
Naeem Noordin, Managing Director, Siara Pte Ltd,
Singapore
17:00 End of Clinical Trial Development in Asia Workshop
8:30 Registration & Morning Coffee
8:50 Introduction
9:00 China Pharmaceutical Market Outlook
• Current pharmaceutical market outlook and progress in China
• Trends and changes in R&D areas of focus in China
• Is it still all about biosimilars in China?
10:00 Morning Networking & Refreshment Break
10:30 Creating Successful Partnerships in China
• Key considerations when partnering with Chinese companies
• Critical advice in getting the most out of your partnership
11:30 R&D Development Models for China
• Crafting a R&D development plan
• How to select a R&D model most suitable for your organization
12:30 Networking Lunch
14:00 Challenges of Selecting and Collaborating with China-
Based Preclinical Contract Laboratories
• Selecting pre-clinical contract laboratories in China
• How to access the cost, facilities and labour skills before selecting
• Tips in maintaining confidentiality and ensuring quality in
preclinical research
15:00 Afternoon Networking & Refreshment Break
16:00 Integrating Regulatory Concerns with Drug
Development in China
• Recent regulatory changes in China
• Overcoming the ever changing regulations during drug
development
17:00 End of China R&D Workshop
Clinical Trial Development
in Asia
This interactive multi-speaker workshop aims to acquaint the
participant with the essential skills to develop a quality and
regulatory compliant clinical trial in Asia.
PRE-CONFERENCE SPECIAL FOCUS DAY
26 AUGUST 2014, TUESDAY (0900 – 1700)
China R&D
This workshop aims to introduce you to one of the world’s largest
and highly competitive markets – the China R&D market. It will
bring you through the important aspects on what is required, the
investments, opportunities and key insights on entering and
operating in the China R&D market.
About Your Workshop Leaders
Gene Ching-Hung Hsu, Senior Vice President,
HEC Pharm Group, China
Dr. Hsu is the Senior Vice President at HEC Pharm Group (China). He
earned his Ph.D. from Massachusetts Institute of Technology (MIT) and
completed his postdoctoral training at University of California at Berkeley.
Prior to HEC Pharm, Dr. Hsu was the Chief Scientific Officer and Vice
President of Shanghai InnoStar Bio-Tech Co. (China). His professional
experience also includes executive and technical positions at TaiGen Biotech Co.
(Taiwan), Merck & Co. (USA), and US Federal Government. Dr. Hsu has co-authored
over 150 scientific publications, book chapters, and technical reports. He publishes
books titled“Clinical Pathology in Experimental Animals”and“Cancer Risk Assessment”
(John Wiley & Sons, Inc.). Currently, Dr. Hsu serves on the Editorial Board of two
international peer-reviewed journals and is the President-Elect of American Association
of Chinese Toxicology (a special interest group of the Society of Toxicology, USA). He
is board-certified by the American Board of Toxicology. Dr. Hsu is a recipient of the
prestigious “Global Expert Award” by the China Central Government
Joe Zhang, Executive Deputy Head, Center of Medical and
Translational Sciences, Shanghai CP Guojian
Pharmaceutical, China
Dr. Zhang joined Shanghai CP Guojian Pharmaceutical Co. Ltd. in February
2014 as the Executive Deputy Head of the Center of Medical and
Translational Sciences, overseeing the entire preclinical (GLP tox) and
clinical (Phase I to IV) development activities of the company. He also
is the architect and a member of the company’s R&D Committee with responsibilities
of reviewing and approving key milestones and associated budget for each R&D
project. Prior to joining Shanghai CP Guojian, Dr. Zhang served quite a number of roles
during his almost 20 years of professional career from scientist to vice president in a
variety of organizations including China FDA, Covance, Boehringer Ingelheim, and
Roche. Dr. Zhang is a pharmaceutical industry veteran trained in the United States and
China with significant experiences in drug R&D activities. He received his Ph.D. in
Toxicology from Indiana University and is a certified toxicologist by American Board
ofToxicology. He also has a medical degree and a MPH from Beijing Medical University.
Dr. Zhang has been very active in different scientific committees and organizations.
He served as a group leader for RDPAC Preclinical Focus Group, a board member for
Genetic Toxicology Association (GTA) and American Chinese Society of Toxicology
(ACSOT) and is currently a full member of SOT, GTA, BioSafe, SAPA, and AACT.
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
IBC
LIFE SCIENCES
26-29
AUGUST 2014
S i n g a p o r e
P A R K R O Y A L
on Beach Road
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
IBC Asia’s premier Pharma R&D Asia conference aims to facilitate
a better understanding of the complex Asian emerging
pharmaceutical R&D industry, the opportunities, the challenges
and the strategies that senior level decision makers are employing
to get the best out of the region. Hear from pharmaceutical R&D
experts on the investment opportunities, clinical trial
developments, regulatory approval progress, technology transfer,
IP protection and more, in this structured learning, networking
and value packed four day program.You will no doubt, go home
with new business relationships and strategies to successfully
grow an innovative R&D pipeline in Asia.
Sponsorship Opportunities
RAISE awareness of your products and services to regional and
international pharmaceutical professionals!
Stand out from the competition with this branding opportunity
Meet and develop new client relationships and also affirm existing ones with your
presence at this event
Are you launching new R&D technology or clinical trials services? Now is the time
to showcase at this event
Raise and maintain your corporate profile edge
To check out our tailored sponsorship solutions, please contact: Yvonne Leong, Business
Development Manager at Tel: +65 6508 2489 or Email: Yvonne.Leong@ibcasia.com.sg
Who You Will Meet
■ Singapore 35%
■ Malaysia 15%
■ Indonesia 10%
■ Thailand 10%
■ India 10%
■ Rest of Sotheast Asia 5%
■ North Asia 10%
■ US/Europe 2%
■ Australia/New Zealand 3%
■ Pharmaceutical/Biotech/Generics 45%
■ Research Institute/Universities 25%
■ Government Agencies 5%
■ CROs 15%
■ Law Firms & Consultants 8%
■ R&D Software Solutions Providers 2%
Partnerships and Collaboration Opportunities
Licensing, M&A Trends in Asia
Regulatory Trends and Their Impact on your R&D Pipeline
Market & Investment Opportunities in Asia
Intellectual Property Right Issues & Patent Strategies in Asia
Outsourcing vs Inhouse R&D
Clinical Trial Requirements & Development
R&D Strategies for an Innovative Product Pipeline
Key Conference Highlights:
Part of:
Showcase Your Research... Present a Poster
If you have new results/data on topics relevant to this conference, we encourage you to submit a poster presentation.
Any registered conference attendee may present a poster. Full payment of conference registration and poster fees must be
received for the abstract to be included in the conference materials and a poster board assignment to be made (see the
registration page for details on the poster fee). Only one poster presentation is allowed per registered attendee/author.
For more information, please email: weifang.sim@ibcasia.com.sg
WHO SHOULD ATTEND?
• Head of Medical Affairs
• Medical Affairs Directors
• MSLs
• Chief Medical Officer
• Scientific Directors
• Medical Directors
• Medical and Scientific Affairs Executives
IBC
LIFE SCIENCES 4 Successful Events Under 1 Roof!
26 - 29 AUGUST 2014 | PARKROYAL ON BEACH ROAD, SINGAPORE
What is PharmaCon?
The Pharmaceutical Congress Asia (PharmaCon) is the leading annual event that brings together Government, pharmaceutical companies and
suppliers in Asia across:
4 Conferences 10 Workshops 4 Days of value-packed information Hours of networking opportunities
The dynamic program and networking platform aims to enable companies to develop strong partnerships, drive innovation and growth, as
well as winning products and services, in Asia’s growing pharmaceutical industry.
Asia’s premier Pharma R&D conference is designed
for professionals in the pharmaceutical R&D sector
to find out the latest investment, partnership and
collaboration opportunities, challenges facing drug
discovery and clinical development and how to
improve R&D innovation and productivity in Asia.
WHO SHOULD ATTEND?
Senior level professionals from:
Designed for regulatory professionals in the
pharmaceutical industry to come together to discuss
effective regulatory strategies for product access
into Asia and also globally as well as to gain clarity
on the complex and ever changing regulations in
the region.
WHO SHOULD ATTEND?
Professionals dealing with:
• Global/Regional Regulatory Affairs
• Regulatory Compliance
• Regulatory Submissions & Publishing
• Pharmacovigilance
• Market Access
Designed for senior executives from marketing in
prescription and consumer health sectors, the
conference pinpoints key success factors in
strategizing pricing, distribution, advertising &
promotion and product differentiation strategy in
this competitive market.This event is Asia’s one and
only platform to provide updated and in-depth
evaluation on marketing strategies in the
pharmaceutical industry.
WHO SHOULD ATTEND?
• CEO
• Chief Marketing Officer
• President/Managing Director/Vice
President of Asia
• Country Manager
• Regional Marketing Director
• Head of Corporate Planning
• Head of Commercialization
• Head of Marketing & Sales
• Head of Market Access
• Head of Business Development
• Head of Multi-Channel Marketing
• Head of Digital Marketing
• Head of Product Development
• Head of Packaging and Labeling
• Head of Procurement & Sourcing
• Head of Compliance
MEDICAL AFFAIRS FORUM ASIA is the region’s
longest running medical affairs forum where best
practices are shared and common issues with like-
minded peers are discussed. This event will bring
insights on how to be more effective in enhancing
your company’s scientific reputation and
communicating the value of your products.
• R&D
• Drug Discovery
• Clinical Trial and
Development
• Business Development
• Partnerships & Licensing
• Strategic Alliance
Management
• Strategy & Portfolio
Management
• Investment
• Mergers & Acquisitions
REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
ENJOY SUBSTANTIAL SAVINGS WITH
OUR MULTIPLE BOOKING DISCOUNT!
REGISTER NOW! FAX BACK TO +65 6508 2407
HOTEL INFORMATION
DATA PROTECTION
PAYMENT TERMS
CANCELLATIONS / SUBSTITUTION
IMPORTANT NOTE
6 EASY WAYS TO REGISTER
Email
register@ibcasia.com.sg
Customer Service Hotline
+65 6508 2401
Fax
+65 6508 2407
Web
www.pharmaconasia.com
❑ Yes! I/We will attend the Pharma R&D Asia 2014 | 26 – 29 August 2014, ParkRoyal Hotel on Beach Road, Singapore
REGNO.200108203N
PHARMA R&D ASIA 2014
❑ I would like to purchase the conference presentations at SGD1000 + GST (SGD1070) per log in.
RESERVE YOUR PLACE TODAY!
CREDIT CARD PAYMENTS
The best way to pay by credit card is through our secure on-line registration process, simply log on to the website at
www.pharmaconasia.com.com and click “Register On-line”. If you would prefer to pay over the phone please complete the contact name
and details and our Customer Services Team will call within 24 hours to take payment. As we treat your credit card information in the strictest
confidence, please do not send payment details by email.
Credit card contact: Department:
Direct phone number: Email:
P46245
Payment Method (Please tick:) ❑ I enclose my bankers draft / cheque payable to IBC Asia (S) Pte Ltd
❑ I am paying by bank transfer (copy attached)
❑ Payment by Credit Card. (AMEX, VISA or MasterCard accepted)
Payment must be received 10 business days prior to the event. To
take advantage of discounts with an expiry date, registration and
payment must be received by the cut-off date.
• Payment by bankers draft or cheque in S$ or US$ should be
made in favour of “IBC Asia (S) Pte Ltd” and mailed to:
IBC Asia (S) Pte Ltd
c/o Informa Regional Business Services
111 Somerset Road, TripleOne Somerset #10-06
Singapore 238164
Attn: The Accounts Receivable Team
• Payment by bank transfer in S$ or US$ made payable to:
IBC Asia (S) Pte Ltd
A/C No.:147-059513-001 (S$)
A/C No.:260-457866-178 (US$)
The Hongkong and Shanghai Banking Corporation Limited
21 Collyer Quay, HSBC Building
Singapore 049320
Bank Swift Code: HSBCSGSG
Bank Code: 7232
• Payment by Credit Card (AMEX, VISA or MasterCard).
The best way to pay by credit card is through our secure portal
built into the website. To pay by phone please indicate the
contact name and details below and our Customer Services
Team will call within 24 hours to take payment. Please do not
send credit card information by email.
SAVE WITH THE
EARLY BIRD &
SPECIAL RATES!
The personal information entered during your registration/order, or
provided by you, will be held on a database and may be shared
with companies in the Informa Group in the UK and internationally.
Occasionally, your details may be obtained from or shared with
external companies who wish to communicate with you offers
related to your business activities. If you do not wish your details
to be used for this purpose, please contact our Database Department
at Email: database@ibcasia.com.sg, Tel: +65 6508 2400 or Fax:
+65 6508 2408.
Should you be unable to attend, a substitute delegate is welcome
at no extra charge. Cancellations must be received in writing at
least 10 business days before the start of the event, to receive a
refund less 10% processing fee per registration. The company
regrets that no refund will be made available for cancellation
notifications received less than 10 business days before the event.
Please quote the name of the delegate, event title and invoice
number on the advice when remitting payment. Bank charges are
to be deducted from participating organisations own accounts.
Please fax your payment details (copy of remittance advice, cheque
or draft to +65 6508 2407).
Attendance will only be permitted upon receipt of full payment.
Participants wishing to register at the door are responsible to ensure
all details are as published. IBC assumes no further liability or
obligation, beyond the refund of the paid registration fee, in the
event of postponement or cancellation by IBC.
MAIL the attached registration form with your
cheque to IBC Asia (S) Pte Ltd
c/o Informa Regional Business Services
111 Somerset Road, TripleOne Somerset
#10-06, Singapore 238164
Scan the QR Code
with your smartphone
and register today
Early Bird Rate
Register & pay on or
before 20 Jun 2014
FEE PER DELEGATE
Special Rate
Register & pay on or
before 18 Jul 2014
Group Rate
(3 or more delegates)
Normal Rate
Register & pay after
18 Jul 2014
❑ 2 Day Conference only
SGD 3,895 SGD 4,095 SGD 4,295 SGD 3,795❑ 4 Day Package: 2 Day Conference + All Workshops
SGD 2,595 SGD 2,795 SGD 2,995 SGD 2,495
• Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time. Fee stated
is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR special rate OR group rate.
• All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
• Registration fees are subject to the prevailing government tax
Who is Head of your Department?
Who is Head of Training?
Company Information
Company Name:
Address:
Main Business/Activity:
Postal Code:
Please photocopy for additional delegates
FREE
GROUPDISCOUNT
Delegate 1 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Delegate 2 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Delegate 3 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
Delegate 4 Details
Name: Dr/Mr/Ms
Job Title:
Department
Tel:
Mobile No.:
Email:
❑ 3 Day Package: 2 Day Conference
❑ Pre-Conference Workshop OR
❑ Post-Conference Workshop
SGD 3,295 SGD 3,495 SGD 3,695 SGD 3,195
PARKROYAL on Beach Road
7500 Beach Road, Singapore 199591
Hotel mainline: +65 6505 5666
Contact Person: Teo Hui Ling
Tel: +65 6505 5696
Email: teo.huiling@parkroyalhotels.com
GROUP BONUS – Register 3 Delegates from the same company and the 4th Delegate attends FREE!
❑ Present a Poster SGD100 for Industry and Free for Academic
4 Successful Events Under 1 Roof
180+ Attendees to Network With
4+ Days of Expert Knowledge Sharing
80+ Expert Pharmaceutical
Stakeholders & Key Decision Makers
15+ Interactive Formats to Get To Know
Your Peers & Customers
1 Joint Exhibition Area
Part of:
spex

Contenu connexe

Tendances

P 045 Partnerships With Cr Os
P 045 Partnerships With Cr OsP 045 Partnerships With Cr Os
P 045 Partnerships With Cr Osnhussain12
 
SMi Group's Ophthalmic Drugs 2019 conference
SMi Group's Ophthalmic Drugs 2019 conferenceSMi Group's Ophthalmic Drugs 2019 conference
SMi Group's Ophthalmic Drugs 2019 conferenceDale Butler
 
SMi Group's Adaptive Designs in Clinical Trials conference
SMi Group's Adaptive Designs in Clinical Trials conferenceSMi Group's Adaptive Designs in Clinical Trials conference
SMi Group's Adaptive Designs in Clinical Trials conferenceDale Butler
 
Introduction to Biodesign - Stanford University - Ravi Pamnani
Introduction to Biodesign - Stanford University - Ravi PamnaniIntroduction to Biodesign - Stanford University - Ravi Pamnani
Introduction to Biodesign - Stanford University - Ravi PamnaniEmpreender Saúde
 
SMi Group's Prefilled Syringes 2016
SMi Group's Prefilled Syringes 2016SMi Group's Prefilled Syringes 2016
SMi Group's Prefilled Syringes 2016Dale Butler
 
The 10 most trusted diagnostics and pathology center.
The 10 most trusted diagnostics and pathology center.The 10 most trusted diagnostics and pathology center.
The 10 most trusted diagnostics and pathology center.Merry D'souza
 
Healthcare Facilities Asia Conference
Healthcare Facilities Asia ConferenceHealthcare Facilities Asia Conference
Healthcare Facilities Asia ConferenceLei Ching Y.
 
The best of 5 diagnostic and pathology centers
The best of 5 diagnostic and pathology centersThe best of 5 diagnostic and pathology centers
The best of 5 diagnostic and pathology centersMerry D'souza
 
The best of 5 diagnostic and pathology centers
The best of 5 diagnostic and pathology centersThe best of 5 diagnostic and pathology centers
The best of 5 diagnostic and pathology centersMerry D'souza
 
How early is too early charles view 5jun2017
How early is too early charles view 5jun2017How early is too early charles view 5jun2017
How early is too early charles view 5jun2017Stephen Murdock
 
SMi Group's 3rd annual Prefilled Syringes East Coast 2016
SMi Group's 3rd annual Prefilled Syringes East Coast 2016SMi Group's 3rd annual Prefilled Syringes East Coast 2016
SMi Group's 3rd annual Prefilled Syringes East Coast 2016Dale Butler
 
P 141 pre-filled syringes america revised
P 141 pre-filled syringes america revisedP 141 pre-filled syringes america revised
P 141 pre-filled syringes america revisedAlia Malick
 
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...Best Practices
 
Market Analysis of Clinical Research in Asia Pacific
Market Analysis of Clinical Research in Asia PacificMarket Analysis of Clinical Research in Asia Pacific
Market Analysis of Clinical Research in Asia PacificClinActis Pte Ltd
 

Tendances (19)

P 045 Partnerships With Cr Os
P 045 Partnerships With Cr OsP 045 Partnerships With Cr Os
P 045 Partnerships With Cr Os
 
Clinical Trials Summit 2015
Clinical Trials Summit 2015Clinical Trials Summit 2015
Clinical Trials Summit 2015
 
SMi Group's Ophthalmic Drugs 2019 conference
SMi Group's Ophthalmic Drugs 2019 conferenceSMi Group's Ophthalmic Drugs 2019 conference
SMi Group's Ophthalmic Drugs 2019 conference
 
SMi Group's Adaptive Designs in Clinical Trials conference
SMi Group's Adaptive Designs in Clinical Trials conferenceSMi Group's Adaptive Designs in Clinical Trials conference
SMi Group's Adaptive Designs in Clinical Trials conference
 
Introduction to Biodesign - Stanford University - Ravi Pamnani
Introduction to Biodesign - Stanford University - Ravi PamnaniIntroduction to Biodesign - Stanford University - Ravi Pamnani
Introduction to Biodesign - Stanford University - Ravi Pamnani
 
SMi Group's Prefilled Syringes 2016
SMi Group's Prefilled Syringes 2016SMi Group's Prefilled Syringes 2016
SMi Group's Prefilled Syringes 2016
 
Biodesign
BiodesignBiodesign
Biodesign
 
The 10 most trusted diagnostics and pathology center.
The 10 most trusted diagnostics and pathology center.The 10 most trusted diagnostics and pathology center.
The 10 most trusted diagnostics and pathology center.
 
Healthcare Facilities Asia Conference
Healthcare Facilities Asia ConferenceHealthcare Facilities Asia Conference
Healthcare Facilities Asia Conference
 
The best of 5 diagnostic and pathology centers
The best of 5 diagnostic and pathology centersThe best of 5 diagnostic and pathology centers
The best of 5 diagnostic and pathology centers
 
The best of 5 diagnostic and pathology centers
The best of 5 diagnostic and pathology centersThe best of 5 diagnostic and pathology centers
The best of 5 diagnostic and pathology centers
 
How early is too early charles view 5jun2017
How early is too early charles view 5jun2017How early is too early charles view 5jun2017
How early is too early charles view 5jun2017
 
SMi Group's 3rd annual Prefilled Syringes East Coast 2016
SMi Group's 3rd annual Prefilled Syringes East Coast 2016SMi Group's 3rd annual Prefilled Syringes East Coast 2016
SMi Group's 3rd annual Prefilled Syringes East Coast 2016
 
Harsh Bal - MDI Gurgaon Invited Seminar - 17 Dec 2012
Harsh Bal - MDI Gurgaon Invited Seminar - 17 Dec 2012Harsh Bal - MDI Gurgaon Invited Seminar - 17 Dec 2012
Harsh Bal - MDI Gurgaon Invited Seminar - 17 Dec 2012
 
P 141 pre-filled syringes america revised
P 141 pre-filled syringes america revisedP 141 pre-filled syringes america revised
P 141 pre-filled syringes america revised
 
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
Success Factors and Failure Points in Biopharmaceutical Product Launches: An ...
 
Neolite Business Credential
Neolite Business CredentialNeolite Business Credential
Neolite Business Credential
 
Market Analysis of Clinical Research in Asia Pacific
Market Analysis of Clinical Research in Asia PacificMarket Analysis of Clinical Research in Asia Pacific
Market Analysis of Clinical Research in Asia Pacific
 
Cro
CroCro
Cro
 

Similaire à Pharmaceutical R&D Asia 2014

Medical Affairs Asia Forum 2014
Medical Affairs Asia Forum 2014 Medical Affairs Asia Forum 2014
Medical Affairs Asia Forum 2014 Rita Barry
 
Biomanufacturing in China: Technologies and Facility Design
Biomanufacturing in China: Technologies and Facility DesignBiomanufacturing in China: Technologies and Facility Design
Biomanufacturing in China: Technologies and Facility DesignRita Barry
 
Biosimilars Asia
Biosimilars Asia Biosimilars Asia
Biosimilars Asia Rita Barry
 
Medical Affairs Asia 2012
Medical Affairs Asia 2012Medical Affairs Asia 2012
Medical Affairs Asia 2012Rita Barry
 
Generics Asia 2014
Generics Asia 2014 Generics Asia 2014
Generics Asia 2014 Rita Barry
 
The 2nd Annual Oncology Asia
The 2nd Annual Oncology AsiaThe 2nd Annual Oncology Asia
The 2nd Annual Oncology Asiahelenph513
 
2nd Med Device Brochure | 16-19 Nov 2015 Singapore
2nd Med Device  Brochure | 16-19 Nov 2015 Singapore2nd Med Device  Brochure | 16-19 Nov 2015 Singapore
2nd Med Device Brochure | 16-19 Nov 2015 SingaporeHelen P
 
5th OTC Pharma Asia Conference
5th OTC Pharma Asia Conference5th OTC Pharma Asia Conference
5th OTC Pharma Asia ConferenceLei Ching Y.
 
6thBiosimilars2015_Shanghai
6thBiosimilars2015_Shanghai6thBiosimilars2015_Shanghai
6thBiosimilars2015_ShanghaiRaj Kannan
 
SMi Group's European BioNetworks Summit
SMi Group's European BioNetworks SummitSMi Group's European BioNetworks Summit
SMi Group's European BioNetworks SummitDale Butler
 
Pharmaceutical Compliance 2015
Pharmaceutical Compliance 2015 Pharmaceutical Compliance 2015
Pharmaceutical Compliance 2015 Rita Barry
 
Biologics World Taiwan 2016 (email me at justin.dejesus@imapac.com)
Biologics World Taiwan 2016 (email me at justin.dejesus@imapac.com) Biologics World Taiwan 2016 (email me at justin.dejesus@imapac.com)
Biologics World Taiwan 2016 (email me at justin.dejesus@imapac.com) Justin Barin de Jesus
 
4th Annual Biomanufacturing Asia
4th Annual Biomanufacturing Asia 4th Annual Biomanufacturing Asia
4th Annual Biomanufacturing Asia Rita Barry
 
OTC Pharma Asia 2015
OTC Pharma Asia 2015 OTC Pharma Asia 2015
OTC Pharma Asia 2015 Rita Barry
 
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 20142nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014Medical Science Liaison Society
 
Animal Health Conference China - featuring senior executives from animal heal...
Animal Health Conference China - featuring senior executives from animal heal...Animal Health Conference China - featuring senior executives from animal heal...
Animal Health Conference China - featuring senior executives from animal heal...Lei Ching Y.
 
SMi Group's Biosimilars & Biobetters USA 2015 conference & exhibition
SMi Group's Biosimilars & Biobetters USA 2015 conference & exhibitionSMi Group's Biosimilars & Biobetters USA 2015 conference & exhibition
SMi Group's Biosimilars & Biobetters USA 2015 conference & exhibitionDale Butler
 

Similaire à Pharmaceutical R&D Asia 2014 (20)

Medical Affairs Asia Forum 2014
Medical Affairs Asia Forum 2014 Medical Affairs Asia Forum 2014
Medical Affairs Asia Forum 2014
 
Biomanufacturing in China: Technologies and Facility Design
Biomanufacturing in China: Technologies and Facility DesignBiomanufacturing in China: Technologies and Facility Design
Biomanufacturing in China: Technologies and Facility Design
 
Oncology asia
Oncology asiaOncology asia
Oncology asia
 
Biosimilars Asia
Biosimilars Asia Biosimilars Asia
Biosimilars Asia
 
Medical Affairs Asia 2012
Medical Affairs Asia 2012Medical Affairs Asia 2012
Medical Affairs Asia 2012
 
Generics Asia 2014
Generics Asia 2014 Generics Asia 2014
Generics Asia 2014
 
The 2nd Annual Oncology Asia
The 2nd Annual Oncology AsiaThe 2nd Annual Oncology Asia
The 2nd Annual Oncology Asia
 
2nd Med Device Brochure | 16-19 Nov 2015 Singapore
2nd Med Device  Brochure | 16-19 Nov 2015 Singapore2nd Med Device  Brochure | 16-19 Nov 2015 Singapore
2nd Med Device Brochure | 16-19 Nov 2015 Singapore
 
5th OTC Pharma Asia Conference
5th OTC Pharma Asia Conference5th OTC Pharma Asia Conference
5th OTC Pharma Asia Conference
 
6thBiosimilars2015_Shanghai
6thBiosimilars2015_Shanghai6thBiosimilars2015_Shanghai
6thBiosimilars2015_Shanghai
 
SMi Group's European BioNetworks Summit
SMi Group's European BioNetworks SummitSMi Group's European BioNetworks Summit
SMi Group's European BioNetworks Summit
 
Pharmaceutical Compliance 2015
Pharmaceutical Compliance 2015 Pharmaceutical Compliance 2015
Pharmaceutical Compliance 2015
 
6th annual clinical trials summit 2015
6th annual clinical trials summit 20156th annual clinical trials summit 2015
6th annual clinical trials summit 2015
 
Biologics World Taiwan 2016 (email me at justin.dejesus@imapac.com)
Biologics World Taiwan 2016 (email me at justin.dejesus@imapac.com) Biologics World Taiwan 2016 (email me at justin.dejesus@imapac.com)
Biologics World Taiwan 2016 (email me at justin.dejesus@imapac.com)
 
4th Annual Biomanufacturing Asia
4th Annual Biomanufacturing Asia 4th Annual Biomanufacturing Asia
4th Annual Biomanufacturing Asia
 
OTC Pharma Asia 2015
OTC Pharma Asia 2015 OTC Pharma Asia 2015
OTC Pharma Asia 2015
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015
 
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 20142nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014
2nd Annual Medical Affairs Leaders Forum Asia- August 5th - 6th, 2014
 
Animal Health Conference China - featuring senior executives from animal heal...
Animal Health Conference China - featuring senior executives from animal heal...Animal Health Conference China - featuring senior executives from animal heal...
Animal Health Conference China - featuring senior executives from animal heal...
 
SMi Group's Biosimilars & Biobetters USA 2015 conference & exhibition
SMi Group's Biosimilars & Biobetters USA 2015 conference & exhibitionSMi Group's Biosimilars & Biobetters USA 2015 conference & exhibition
SMi Group's Biosimilars & Biobetters USA 2015 conference & exhibition
 

Plus de Rita Barry

The time for SIEM
The time for SIEM The time for SIEM
The time for SIEM Rita Barry
 
Factors to keep in mind when you’re considering cloud storage services.
Factors to keep in mind when you’re considering cloud storage services.Factors to keep in mind when you’re considering cloud storage services.
Factors to keep in mind when you’re considering cloud storage services.Rita Barry
 
Why so many SIEM Implmentations Fail
Why so many SIEM Implmentations FailWhy so many SIEM Implmentations Fail
Why so many SIEM Implmentations FailRita Barry
 
Carve-outs and Mergers and Acquisitions place unique demands on IT. How can y...
Carve-outs and Mergers and Acquisitions place unique demands on IT. How can y...Carve-outs and Mergers and Acquisitions place unique demands on IT. How can y...
Carve-outs and Mergers and Acquisitions place unique demands on IT. How can y...Rita Barry
 
Tertiary Hospital Services 2015
Tertiary Hospital Services 2015 Tertiary Hospital Services 2015
Tertiary Hospital Services 2015 Rita Barry
 
Biopharma Production & Development Week 2015
Biopharma Production & Development Week 2015 Biopharma Production & Development Week 2015
Biopharma Production & Development Week 2015 Rita Barry
 
Cell Line Development and Engineering 2015
Cell Line Development and Engineering 2015 Cell Line Development and Engineering 2015
Cell Line Development and Engineering 2015 Rita Barry
 
5th Annual BioManufacturing Asia 2015
5th Annual BioManufacturing Asia 2015 5th Annual BioManufacturing Asia 2015
5th Annual BioManufacturing Asia 2015 Rita Barry
 
Philippines healthcare 2015
Philippines healthcare 2015Philippines healthcare 2015
Philippines healthcare 2015Rita Barry
 
9th Clearing, Settlement Custody Asia
9th Clearing, Settlement Custody Asia9th Clearing, Settlement Custody Asia
9th Clearing, Settlement Custody AsiaRita Barry
 
Biopharma Production and Development China 2015
Biopharma Production and Development China 2015 Biopharma Production and Development China 2015
Biopharma Production and Development China 2015 Rita Barry
 
Offshore RMB 2014
Offshore RMB 2014 Offshore RMB 2014
Offshore RMB 2014 Rita Barry
 
Indonesia Healthcare 2014
Indonesia Healthcare 2014 Indonesia Healthcare 2014
Indonesia Healthcare 2014 Rita Barry
 
PharmaCon - Pharmaceutical Congress Asia 2014
PharmaCon - Pharmaceutical Congress Asia 2014 PharmaCon - Pharmaceutical Congress Asia 2014
PharmaCon - Pharmaceutical Congress Asia 2014 Rita Barry
 
Bioprocess International China 2014
Bioprocess International China 2014 Bioprocess International China 2014
Bioprocess International China 2014 Rita Barry
 
ISPE Singapore 2014
ISPE Singapore 2014 ISPE Singapore 2014
ISPE Singapore 2014 Rita Barry
 
Electronic Health Records Asia
Electronic Health Records Asia Electronic Health Records Asia
Electronic Health Records Asia Rita Barry
 
Partnerships in Clinical Trials China
Partnerships in Clinical Trials China Partnerships in Clinical Trials China
Partnerships in Clinical Trials China Rita Barry
 
Biopharma Production & Development Week 2014
Biopharma Production & Development Week 2014Biopharma Production & Development Week 2014
Biopharma Production & Development Week 2014Rita Barry
 

Plus de Rita Barry (20)

The time for SIEM
The time for SIEM The time for SIEM
The time for SIEM
 
Factors to keep in mind when you’re considering cloud storage services.
Factors to keep in mind when you’re considering cloud storage services.Factors to keep in mind when you’re considering cloud storage services.
Factors to keep in mind when you’re considering cloud storage services.
 
Why so many SIEM Implmentations Fail
Why so many SIEM Implmentations FailWhy so many SIEM Implmentations Fail
Why so many SIEM Implmentations Fail
 
Carve-outs and Mergers and Acquisitions place unique demands on IT. How can y...
Carve-outs and Mergers and Acquisitions place unique demands on IT. How can y...Carve-outs and Mergers and Acquisitions place unique demands on IT. How can y...
Carve-outs and Mergers and Acquisitions place unique demands on IT. How can y...
 
Hf asia15
Hf asia15Hf asia15
Hf asia15
 
Tertiary Hospital Services 2015
Tertiary Hospital Services 2015 Tertiary Hospital Services 2015
Tertiary Hospital Services 2015
 
Biopharma Production & Development Week 2015
Biopharma Production & Development Week 2015 Biopharma Production & Development Week 2015
Biopharma Production & Development Week 2015
 
Cell Line Development and Engineering 2015
Cell Line Development and Engineering 2015 Cell Line Development and Engineering 2015
Cell Line Development and Engineering 2015
 
5th Annual BioManufacturing Asia 2015
5th Annual BioManufacturing Asia 2015 5th Annual BioManufacturing Asia 2015
5th Annual BioManufacturing Asia 2015
 
Philippines healthcare 2015
Philippines healthcare 2015Philippines healthcare 2015
Philippines healthcare 2015
 
9th Clearing, Settlement Custody Asia
9th Clearing, Settlement Custody Asia9th Clearing, Settlement Custody Asia
9th Clearing, Settlement Custody Asia
 
Biopharma Production and Development China 2015
Biopharma Production and Development China 2015 Biopharma Production and Development China 2015
Biopharma Production and Development China 2015
 
Offshore RMB 2014
Offshore RMB 2014 Offshore RMB 2014
Offshore RMB 2014
 
Indonesia Healthcare 2014
Indonesia Healthcare 2014 Indonesia Healthcare 2014
Indonesia Healthcare 2014
 
PharmaCon - Pharmaceutical Congress Asia 2014
PharmaCon - Pharmaceutical Congress Asia 2014 PharmaCon - Pharmaceutical Congress Asia 2014
PharmaCon - Pharmaceutical Congress Asia 2014
 
Bioprocess International China 2014
Bioprocess International China 2014 Bioprocess International China 2014
Bioprocess International China 2014
 
ISPE Singapore 2014
ISPE Singapore 2014 ISPE Singapore 2014
ISPE Singapore 2014
 
Electronic Health Records Asia
Electronic Health Records Asia Electronic Health Records Asia
Electronic Health Records Asia
 
Partnerships in Clinical Trials China
Partnerships in Clinical Trials China Partnerships in Clinical Trials China
Partnerships in Clinical Trials China
 
Biopharma Production & Development Week 2014
Biopharma Production & Development Week 2014Biopharma Production & Development Week 2014
Biopharma Production & Development Week 2014
 

Dernier

Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato pptElizangelaSoaresdaCo
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBBPMedia1
 
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdfTalent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdfCharles Cotter, PhD
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Onlinelng ths
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Winbusinessin
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsP&CO
 
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...AustraliaChapterIIBA
 
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHelene Heckrotte
 
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfPDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfHajeJanKamps
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...Brian Solis
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZKanakChauhan5
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGlokeshwarmaha
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinAnton Skornyakov
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentationbaron83
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyHanna Klim
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024Stephan Koning
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessAPCO
 
Live-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarLive-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarNathanielSchmuck
 

Dernier (20)

Plano de marketing- inglês em formato ppt
Plano de marketing- inglês  em formato pptPlano de marketing- inglês  em formato ppt
Plano de marketing- inglês em formato ppt
 
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John MeulemansBCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
BCE24 | Virtual Brand Ambassadors: Making Brands Personal - John Meulemans
 
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdfTalent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
Talent Management research intelligence_13 paradigm shifts_20 March 2024.pdf
 
To Create Your Own Wig Online To Create Your Own Wig Online
To Create Your Own Wig Online  To Create Your Own Wig OnlineTo Create Your Own Wig Online  To Create Your Own Wig Online
To Create Your Own Wig Online To Create Your Own Wig Online
 
Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024Borderless Access - Global Panel book-unlock 2024
Borderless Access - Global Panel book-unlock 2024
 
Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024Ethical stalking by Mark Williams. UpliftLive 2024
Ethical stalking by Mark Williams. UpliftLive 2024
 
Entrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizationsEntrepreneurship & organisations: influences and organizations
Entrepreneurship & organisations: influences and organizations
 
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...
IIBA® Melbourne - Navigating Business Analysis - Excellence for Career Growth...
 
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptxHELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
HELENE HECKROTTE'S PROFESSIONAL PORTFOLIO.pptx
 
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdfPDT 89 - $1.4M - Seed - Plantee Innovations.pdf
PDT 89 - $1.4M - Seed - Plantee Innovations.pdf
 
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
The End of Business as Usual: Rewire the Way You Work to Succeed in the Consu...
 
Mihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZMihir Menda - Member of Supervisory Board at RMZ
Mihir Menda - Member of Supervisory Board at RMZ
 
Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024Borderless Access - Global B2B Panel book-unlock 2024
Borderless Access - Global B2B Panel book-unlock 2024
 
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISINGUNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
UNLEASHING THE POWER OF PROGRAMMATIC ADVERTISING
 
Slicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup BerlinSlicing Work on Business Agility Meetup Berlin
Slicing Work on Business Agility Meetup Berlin
 
MoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor PresentationMoneyBridge Pitch Deck - Investor Presentation
MoneyBridge Pitch Deck - Investor Presentation
 
Anyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agencyAnyhr.io | Presentation HR&Recruiting agency
Anyhr.io | Presentation HR&Recruiting agency
 
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 Building Your Personal Brand on LinkedIn - Expert Planet-  2024 Building Your Personal Brand on LinkedIn - Expert Planet-  2024
Building Your Personal Brand on LinkedIn - Expert Planet- 2024
 
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for BusinessQ2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
Q2 2024 APCO Geopolitical Radar - The Global Operating Environment for Business
 
Live-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry WebinarLive-Streaming in the Music Industry Webinar
Live-Streaming in the Music Industry Webinar
 

Pharmaceutical R&D Asia 2014

  • 1. IBC LIFE SCIENCES Produced by: International Marketing Partner: Media Partners: 26-29 AUGUST 2014 S i n g a p o r e Featuring Expert Insights Part of: Why You Must Attend Hear from 25+ R&D Expert Speakers Gain Insights on Licensing, M&A, Regulations and More! R&D Investment and Funding Opportunities from Leading Venture Capitalists Craft IP Strategies and Ensure Formula Confidentiality in the Asian region New Interactive and In-Depth Formats: Panel Discussions, Roundtable Discussions, VIP Lunch Tables Jun Bao Senior Vice President & Chief Business Officer, Shenogen Pharma Group, China Joe Zhang Executive Deputy Head, Center of Medical and Translational Sciences, Shanghai CP Guojian Pharmaceutical, China Kantharaj Ethirajulu Head,Research&Development, Technical- Drug Discovery & Development, The Biomedical Sciences Institute (BMSI), Singapore Ben Ni Head & Senior Director, Partnering & External Innovation, Sanofi R&D, China Dr. Narendra Vutla Executive Vice President & Head of R&D-Wellness, Oral Health & Site Operations, GSK Consumer Healthcare, India P A R K R O Y A L on Beach Road Pre- Conference Special Focus Day 26 August 2014 • 9am – 5pm Clinical Trial Development in Asia Post Conference Workshop 29 August 2014 • 9am – 5pm China R&D www.pharmaconasia.com Peter W. Tsao Vice President Business Development, TaiGen Biotechnology, Taiwan Supported by: Sponsors: Life Sciences
  • 2. 8:00 Registration Opens & Morning Coffee 8:50 Welcome from IBC Asia & Morning Ice Breaker 9:00 Chairperson’s Opening Remarks Asia’s Pharmaceutical Market Outlook & Regulatory Updates 9:10 Asia Pharmaceutical Investment Opportunities & Development • Where is the Asian pharmaceutical market heading towards? • What are the investment and market opportunities available in Asia? • How are pharma companies in Asia coping with intensifying competition and investment from overseas? • Selecting the best business model, communication and operations to maximize market share in Asia • How regional integration has affected product launch and marketing in the prescription and non-prescription market Jun Bao, Senior Vice President & Chief Business Officer, Shenogen Pharma Group, China Billy Sarvanantham Urudr, Chief Commercial Officer, CCM Pharmaceuticals Sdn Bhd, Malaysia Dr. Narendra Vutla, Executive Vice President & Head of R&D – Wellness, Oral Health & Site Operations, GSK Consumer Healthcare, India Carl Firth, CEO, Asia Pharmaceuticals, Singapore 10:00 Asia’s Evolving Regulatory Landscape & Development • Current initiatives and regulatory trends in Southeast Asia • International models, frameworks and standards for Asia to adopt • Regulatory trends and their impact on R&D investment • Recent pharma marketing regulations changes, expected new guidelines and compliance process under AEC • Are pharma companies ready for the implementation and the liberalization of health care services? • Current regulatory challenges faced and how they can be tackled • ASEAN harmonization and to what extent will it drive Asian innovation? Joy Chen, Director, Regulatory Affairs, Reckitt Benckiser, Singapore ArielValencia, DeputyDirector, Food & Drug Administration, Philippines Koichi Miyazaki, Senior Director, Regulatory Affairs Group, Asia Development Department, Daiichi Sankyo, Japan 10:40 Morning Networking & Refreshment Break Financing, Partnerships & Collaboration 11.25 Chairperson’s Opening Remarks Jun Bao, Senior Vice President & Chief Business Officer, Shenogen Pharma Group, China 11.30 Strategic Partnerships & Collaboration as a Key to Driving Asian Drug Innovation • Introduction to a multi collaboration and partnership model to drive innovation • Getting the best out of your partnerships • Approaches to incorporate partnerships into your R&D model Ben Ni, Head&SeniorDirector,Partnering&ExternalInnovation, Sanofi R&D, China 12.10 Strategic Licensing, Mergers & Acquisitions Trends for Pharma R&D Development • Evaluating recent licensing and M&A trends in Asia • What do these trends signify? • Different licensing trends for large and small companies, its challenges and how they can be tackled • Where is the Asian pharmaceutical market headed to? Yariv Hefez, Vice President Business Development, Portfolio Management, Strategy and Partnering, Biosimilars Unit, Merck Serono, Switzerland Peter W. Tsao, Vice President Business Development, TaiGen Biotechnology, Taiwan REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com 27 CONFERENCE DAY ONE AUGUST 2014 | Wednesday VISIONARYKEYNOTE 12:50 Speed Networking 13:00 Networking Lunch Have a chance to have an informal chat withVIP guests during the networking lunch break VIP 1: Yuan Hua Ding, Senior Director & Head of External R&D Innovation – Asia, Pfizer Worldwide Research & Development, Pfizer, USA VIP 2: Ben Ni, Head & Senior Director, Partnering & External Innovation, Sanofi R&D, China 14:00 Venture Capital Opportunities for Drug Discovery & Development in Asia • Funding models and investment opportunities in Asia • Latest innovations and fields that are gathering interests among venture capitalists • What constitutes a good business model and presentation • Collaboration opportunities with venture capitalists • Key criteria for investment Goro Takeda, Venture Partner, Sofinnova Ventures, Japan Jun Wu, Chairman & Managing Director, Cenova Ventures, China Jason Mann, ManagingDirector, Fenex Capital Management, China 14:40 Discovery Outsourcing to Asia: Lessons Learnt • What are the challenges faced by a global western company when outsourcing to Asia? • Key concerns from the West • What approach was taken when tackling the challenges faced in Asia? 15:10 Afternoon Networking & Refreshment Break Clinical Trial Development in Asia 15:50 Managing Risks in Clinical Outsourcing to Southeast Asia • Understanding regulations, clinical infrastructure and risks when conducting clinical trials in Asia • Handling ethnicity and cultural differences within Southeast Asia: What are the differences and similarities in risks? • Strategies to minimize and manage these risks • EstablishingstandardsandIPprotectioninclinicaltrialsinSoutheast Asia 16:30 Developing Clinical Trials in Oncology in Singapore • Difficulties faced in conducting oncology clinical research and how were they tackled • Advice in clinical trials design for oncology in Singapore • Tackling oncology clinical trials unique risks and managing them • Ways to carry out the trials efficiently without compromising on quality and safety Joanne Chio, Head, Clinical Trials, Haematology-Oncology Research Group, National University Cancer Institute (NCIS), National University Hospital, Singapore Intellectual Property Rights 17:00 IP Trends & Patent Strategies • Insight into compulsory licensing in India and Indonesia • Viewpoint of the compulsory licensing system in Asia • Singapore’s patent linking system for generics • What are the common issues in intellectual property and how can they be addressed? • Laws protecting and ensuring confidentiality when conducting research in Asia Debolina Partap, Associate Vice President & Head of Legal, Wockhardt Group, India SohKarLiang, ManagingDirector, EllaCheongLLC, Singapore Manh Hung Tran, Principal & Managing Lawyer, BMVN International LLC, a member of Baker & McKenzie International, Vietnam 17:40 Chairperson’s Summary of the Day & End of Conference Day One PANELDISCUSSION PANELDISCUSSIONPANELDISCUSSION PANELDISCUSSION
  • 3. 8:30 Morning Networking & Coffee 9:00 Chairperson’s Opening Remarks Kantharaj Ethirajulu, Head,Research&Development,Technical – Drug Discovery & Development, The Biomedical Sciences Institute (BMSI), Singapore Generics & Biosimilars R&D in Asia 9:10 Biosimilars & Generics R&D in Asia – What Can We Do To Maintain the Lead? • Overview of the generics and biosimilars industry in Asia • A review of science and technology developments for making complex generic drugs • Strategies in retaining Asia’s stronghold in follow-on drug R&D to ensure Return On Investment (ROI) in sales • If not follow-on drugs, what’s next? Moderator Gene Ching-Hung Hsu, Senior Vice President, HEC Pharm Group, China Panelists Kasibhatta Ravisekhar, Vice President, Clinical Research, Lupin Pharmaceuticals, India Qiang Lu, Chief Scientific Officer, Yangtze River Pharmaceutical Group, China Joe Zhang, Executive Deputy Head, Center of Medical and TranslationalSciences, Shanghai CP Guojian Pharmaceutical, China 9:50 Morning Networking & Refreshment Break Driving Drug Innovation in R&D 10:20 Biomedical Innovation & Pharmaceutical Growth • How is pharmaceutical growth in Asia fueling biomedical innovation in the region? • Potential and current growth areas of focus in Asian biomedical innovation • Challenges Asia is facing that could limit its growth potential and what can be done Yuan Hua Ding, Senior Director & Head of External R&D Innovation – Asia, Pfizer Worldwide Research & Development, USA 11:00 Challenges in Drug Discovery & Development in Asia • Challenges faced in Asia and how to tackle them • Overcoming lack of fundamental knowledge for drug discovery • Streamlining drug development process for efficiency • Drug candidates discovered and developed in Asia Kantharaj Ethirajulu, Head,Research&Development,Technical – Drug Discovery and Development, The Biomedical Sciences Institute (BMSI), Singapore Scientific Advances Showcase 11:40 Aggregation in Biosimilars: Orthogonal Analytical Tools in Assessment of Monoclonal Antibodies • Developing analytical methods to study structural change in biosimilar monoclonal antibodies • Eliminating structural change due to change in process conditions • Minimizing structural modifications without compromising on potency of drug Dr. Kalyan Sundaram, Senior Research Scientist, Lupin, India 12:20 Networking Lunch 13:40 Drug Discovery from Natural Medicines by Novel Approaches • Post-absorption/metabolism drugs (PAMD ) concept • Discovery of active metabolite in ginseng which is currently in phase III clinical trials for anti-depression • Results of pharmacokinetics/pharmacodynamics (PK/PD) studies of the metabolite and clinical trials • Future work and initiatives in areas of natural products drug discovery William Jia, Chief Scientific Advisor, SAPHRONTM Database Service Centre, Shanghai Innovative Research Centre of Traditional Chinese Medicine (SIRC/TCM), China Infrastructure & Resource Development for R&D 14:20 Establishing R&D Infrastructure & Talent Resources • Current status of clinical and R&D facilities infrastructure • What are governments in the region doing to improve and promote clinical and R&D development? • Creating a quality and innovative facility in the Philippines: What is required? • Current R&D talent pool outlook in the Philippines • What can be done to further develop, attract and retain R&D talent? Rodel Sibulo, Director of R&D, Pascual Laboratories, Philippines Technology Transfer in Drug Discovery R&D 15:00 Ensuring Reproducibility during Knowledge &Technology Transfer in R&D Outsourcing • Determining the right conditions for technology transfer • Partnering and selecting the right organizations for collaboration • Advice and methods in ensuring data quality and reproducibility during knowledge transfer • Getting the maximum benefits out of the collaboration Qiang Lu, Chief Scientific Officer, Yangtze River Pharmaceutical Group, China 15:40 Afternoon Networking & Refreshment Break Interactive Round Table Sessions 16:20 Roundtable 1: Pharmacokinetics/pharmacodynamics (PK/PD) Guided Clinical Research for Generics Kasibhatta Ravisekhar, Vice President, Clinical Research, Lupin Pharmaceuticals, India ____________________________________________________ Roundtable 2: Inhouse vs Outsourced R&D Hwee Ching Ang , Head of Science Hub, Singapore Region Global External Innovation & Alliances, Bayer Healthcare, Singapore ____________________________________________________ Roundtable 3: R&D Strategies for an Innovative Pipeline James Garner, Head, Unit Operations, Sanofi-Aventis, Singapore 17:40 Chairperson’s Closing Remarks & End of the Pharmaceutical R&D Conference 28 CONFERENCE DAY TWO AUGUST 2014 | Thursday REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com NEWDATA NEWDATAPANELDISCUSSION
  • 4. POST-CONFERENCE WORKSHOP 29 AUGUST 2014, FRIDAY (0900 – 1700) WORKSHOPS 8:30 Registration & Morning Coffee 8:50 Introduction Naeem Noordin, Managing Director, Siara Pte Ltd, Singapore 9:00 Session 1: Clinical Trial Requirements & Regulations in Asia • Insights into clinical trials requirements and regulations in Asia Pacific • Preparing for a regulatory inspection and tips on what the regulators are looking for • Crafting and submitting what is required in a clinical trial application (CTA) Christophe Tournerie, CEO, ClinActis, Singapore 10:30 Morning Networking & Refreshment Break 11:00 Improving & Ensuring the Quality of Clinical Trials & Data • Quality standards in clinical trials • Strategies to ensure, monitor and improve clinical trials data quality during outsourcing of clinical trials • Creating a strategy to minimize risks for data integrity Emily Tan, Vice President, Clinical Operations Asia Pacific, inVentiv Health Clinical, Singapore 12:30 Networking Lunch Break 13:30 Clinical Site Management & Use of Site Management Organizations (SMO) • Selection and evaluation of a clinical trial site • Integration of a quality system, SOPs and training to ensure quality trial data in different clinical sites • Employing a risk based management to ensure clinical quality at site • Use of site management organization (SMO) Shashi Adsul, Head of Clinical Operations, South East Asia, Boehringer-Ingelheim, Singapore 14:30 Application of Digital Technologies for Patient Recruitment & Retention • Utilizing digital technologies for a patient centric and efficient patient recruitment procedure • Cutting costs and time through digital recruitment • Case studies and applications Ramita Tandon, Senior Vice President & General Manager, inVentiv Health ClinicalTrial Recruitment Solutions, USA 15:30 Afternoon Networking & Refreshment Break 16:00 Informed Consent in Clinical Trials • Informed consent implementation process, guidelines and the people involved • Systematic development of the informed consent form • Cultural issues and challenges to be taken into consideration Naeem Noordin, Managing Director, Siara Pte Ltd, Singapore 17:00 End of Clinical Trial Development in Asia Workshop 8:30 Registration & Morning Coffee 8:50 Introduction 9:00 China Pharmaceutical Market Outlook • Current pharmaceutical market outlook and progress in China • Trends and changes in R&D areas of focus in China • Is it still all about biosimilars in China? 10:00 Morning Networking & Refreshment Break 10:30 Creating Successful Partnerships in China • Key considerations when partnering with Chinese companies • Critical advice in getting the most out of your partnership 11:30 R&D Development Models for China • Crafting a R&D development plan • How to select a R&D model most suitable for your organization 12:30 Networking Lunch 14:00 Challenges of Selecting and Collaborating with China- Based Preclinical Contract Laboratories • Selecting pre-clinical contract laboratories in China • How to access the cost, facilities and labour skills before selecting • Tips in maintaining confidentiality and ensuring quality in preclinical research 15:00 Afternoon Networking & Refreshment Break 16:00 Integrating Regulatory Concerns with Drug Development in China • Recent regulatory changes in China • Overcoming the ever changing regulations during drug development 17:00 End of China R&D Workshop Clinical Trial Development in Asia This interactive multi-speaker workshop aims to acquaint the participant with the essential skills to develop a quality and regulatory compliant clinical trial in Asia. PRE-CONFERENCE SPECIAL FOCUS DAY 26 AUGUST 2014, TUESDAY (0900 – 1700) China R&D This workshop aims to introduce you to one of the world’s largest and highly competitive markets – the China R&D market. It will bring you through the important aspects on what is required, the investments, opportunities and key insights on entering and operating in the China R&D market. About Your Workshop Leaders Gene Ching-Hung Hsu, Senior Vice President, HEC Pharm Group, China Dr. Hsu is the Senior Vice President at HEC Pharm Group (China). He earned his Ph.D. from Massachusetts Institute of Technology (MIT) and completed his postdoctoral training at University of California at Berkeley. Prior to HEC Pharm, Dr. Hsu was the Chief Scientific Officer and Vice President of Shanghai InnoStar Bio-Tech Co. (China). His professional experience also includes executive and technical positions at TaiGen Biotech Co. (Taiwan), Merck & Co. (USA), and US Federal Government. Dr. Hsu has co-authored over 150 scientific publications, book chapters, and technical reports. He publishes books titled“Clinical Pathology in Experimental Animals”and“Cancer Risk Assessment” (John Wiley & Sons, Inc.). Currently, Dr. Hsu serves on the Editorial Board of two international peer-reviewed journals and is the President-Elect of American Association of Chinese Toxicology (a special interest group of the Society of Toxicology, USA). He is board-certified by the American Board of Toxicology. Dr. Hsu is a recipient of the prestigious “Global Expert Award” by the China Central Government Joe Zhang, Executive Deputy Head, Center of Medical and Translational Sciences, Shanghai CP Guojian Pharmaceutical, China Dr. Zhang joined Shanghai CP Guojian Pharmaceutical Co. Ltd. in February 2014 as the Executive Deputy Head of the Center of Medical and Translational Sciences, overseeing the entire preclinical (GLP tox) and clinical (Phase I to IV) development activities of the company. He also is the architect and a member of the company’s R&D Committee with responsibilities of reviewing and approving key milestones and associated budget for each R&D project. Prior to joining Shanghai CP Guojian, Dr. Zhang served quite a number of roles during his almost 20 years of professional career from scientist to vice president in a variety of organizations including China FDA, Covance, Boehringer Ingelheim, and Roche. Dr. Zhang is a pharmaceutical industry veteran trained in the United States and China with significant experiences in drug R&D activities. He received his Ph.D. in Toxicology from Indiana University and is a certified toxicologist by American Board ofToxicology. He also has a medical degree and a MPH from Beijing Medical University. Dr. Zhang has been very active in different scientific committees and organizations. He served as a group leader for RDPAC Preclinical Focus Group, a board member for Genetic Toxicology Association (GTA) and American Chinese Society of Toxicology (ACSOT) and is currently a full member of SOT, GTA, BioSafe, SAPA, and AACT. REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
  • 5. IBC LIFE SCIENCES 26-29 AUGUST 2014 S i n g a p o r e P A R K R O Y A L on Beach Road REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com IBC Asia’s premier Pharma R&D Asia conference aims to facilitate a better understanding of the complex Asian emerging pharmaceutical R&D industry, the opportunities, the challenges and the strategies that senior level decision makers are employing to get the best out of the region. Hear from pharmaceutical R&D experts on the investment opportunities, clinical trial developments, regulatory approval progress, technology transfer, IP protection and more, in this structured learning, networking and value packed four day program.You will no doubt, go home with new business relationships and strategies to successfully grow an innovative R&D pipeline in Asia. Sponsorship Opportunities RAISE awareness of your products and services to regional and international pharmaceutical professionals! Stand out from the competition with this branding opportunity Meet and develop new client relationships and also affirm existing ones with your presence at this event Are you launching new R&D technology or clinical trials services? Now is the time to showcase at this event Raise and maintain your corporate profile edge To check out our tailored sponsorship solutions, please contact: Yvonne Leong, Business Development Manager at Tel: +65 6508 2489 or Email: Yvonne.Leong@ibcasia.com.sg Who You Will Meet ■ Singapore 35% ■ Malaysia 15% ■ Indonesia 10% ■ Thailand 10% ■ India 10% ■ Rest of Sotheast Asia 5% ■ North Asia 10% ■ US/Europe 2% ■ Australia/New Zealand 3% ■ Pharmaceutical/Biotech/Generics 45% ■ Research Institute/Universities 25% ■ Government Agencies 5% ■ CROs 15% ■ Law Firms & Consultants 8% ■ R&D Software Solutions Providers 2% Partnerships and Collaboration Opportunities Licensing, M&A Trends in Asia Regulatory Trends and Their Impact on your R&D Pipeline Market & Investment Opportunities in Asia Intellectual Property Right Issues & Patent Strategies in Asia Outsourcing vs Inhouse R&D Clinical Trial Requirements & Development R&D Strategies for an Innovative Product Pipeline Key Conference Highlights: Part of: Showcase Your Research... Present a Poster If you have new results/data on topics relevant to this conference, we encourage you to submit a poster presentation. Any registered conference attendee may present a poster. Full payment of conference registration and poster fees must be received for the abstract to be included in the conference materials and a poster board assignment to be made (see the registration page for details on the poster fee). Only one poster presentation is allowed per registered attendee/author. For more information, please email: weifang.sim@ibcasia.com.sg
  • 6. WHO SHOULD ATTEND? • Head of Medical Affairs • Medical Affairs Directors • MSLs • Chief Medical Officer • Scientific Directors • Medical Directors • Medical and Scientific Affairs Executives IBC LIFE SCIENCES 4 Successful Events Under 1 Roof! 26 - 29 AUGUST 2014 | PARKROYAL ON BEACH ROAD, SINGAPORE What is PharmaCon? The Pharmaceutical Congress Asia (PharmaCon) is the leading annual event that brings together Government, pharmaceutical companies and suppliers in Asia across: 4 Conferences 10 Workshops 4 Days of value-packed information Hours of networking opportunities The dynamic program and networking platform aims to enable companies to develop strong partnerships, drive innovation and growth, as well as winning products and services, in Asia’s growing pharmaceutical industry. Asia’s premier Pharma R&D conference is designed for professionals in the pharmaceutical R&D sector to find out the latest investment, partnership and collaboration opportunities, challenges facing drug discovery and clinical development and how to improve R&D innovation and productivity in Asia. WHO SHOULD ATTEND? Senior level professionals from: Designed for regulatory professionals in the pharmaceutical industry to come together to discuss effective regulatory strategies for product access into Asia and also globally as well as to gain clarity on the complex and ever changing regulations in the region. WHO SHOULD ATTEND? Professionals dealing with: • Global/Regional Regulatory Affairs • Regulatory Compliance • Regulatory Submissions & Publishing • Pharmacovigilance • Market Access Designed for senior executives from marketing in prescription and consumer health sectors, the conference pinpoints key success factors in strategizing pricing, distribution, advertising & promotion and product differentiation strategy in this competitive market.This event is Asia’s one and only platform to provide updated and in-depth evaluation on marketing strategies in the pharmaceutical industry. WHO SHOULD ATTEND? • CEO • Chief Marketing Officer • President/Managing Director/Vice President of Asia • Country Manager • Regional Marketing Director • Head of Corporate Planning • Head of Commercialization • Head of Marketing & Sales • Head of Market Access • Head of Business Development • Head of Multi-Channel Marketing • Head of Digital Marketing • Head of Product Development • Head of Packaging and Labeling • Head of Procurement & Sourcing • Head of Compliance MEDICAL AFFAIRS FORUM ASIA is the region’s longest running medical affairs forum where best practices are shared and common issues with like- minded peers are discussed. This event will bring insights on how to be more effective in enhancing your company’s scientific reputation and communicating the value of your products. • R&D • Drug Discovery • Clinical Trial and Development • Business Development • Partnerships & Licensing • Strategic Alliance Management • Strategy & Portfolio Management • Investment • Mergers & Acquisitions REGISTER TODAY! +65 6508 2401 register@ibcasia.com.sg www.pharmaconasia.com
  • 7. ENJOY SUBSTANTIAL SAVINGS WITH OUR MULTIPLE BOOKING DISCOUNT! REGISTER NOW! FAX BACK TO +65 6508 2407 HOTEL INFORMATION DATA PROTECTION PAYMENT TERMS CANCELLATIONS / SUBSTITUTION IMPORTANT NOTE 6 EASY WAYS TO REGISTER Email register@ibcasia.com.sg Customer Service Hotline +65 6508 2401 Fax +65 6508 2407 Web www.pharmaconasia.com ❑ Yes! I/We will attend the Pharma R&D Asia 2014 | 26 – 29 August 2014, ParkRoyal Hotel on Beach Road, Singapore REGNO.200108203N PHARMA R&D ASIA 2014 ❑ I would like to purchase the conference presentations at SGD1000 + GST (SGD1070) per log in. RESERVE YOUR PLACE TODAY! CREDIT CARD PAYMENTS The best way to pay by credit card is through our secure on-line registration process, simply log on to the website at www.pharmaconasia.com.com and click “Register On-line”. If you would prefer to pay over the phone please complete the contact name and details and our Customer Services Team will call within 24 hours to take payment. As we treat your credit card information in the strictest confidence, please do not send payment details by email. Credit card contact: Department: Direct phone number: Email: P46245 Payment Method (Please tick:) ❑ I enclose my bankers draft / cheque payable to IBC Asia (S) Pte Ltd ❑ I am paying by bank transfer (copy attached) ❑ Payment by Credit Card. (AMEX, VISA or MasterCard accepted) Payment must be received 10 business days prior to the event. To take advantage of discounts with an expiry date, registration and payment must be received by the cut-off date. • Payment by bankers draft or cheque in S$ or US$ should be made in favour of “IBC Asia (S) Pte Ltd” and mailed to: IBC Asia (S) Pte Ltd c/o Informa Regional Business Services 111 Somerset Road, TripleOne Somerset #10-06 Singapore 238164 Attn: The Accounts Receivable Team • Payment by bank transfer in S$ or US$ made payable to: IBC Asia (S) Pte Ltd A/C No.:147-059513-001 (S$) A/C No.:260-457866-178 (US$) The Hongkong and Shanghai Banking Corporation Limited 21 Collyer Quay, HSBC Building Singapore 049320 Bank Swift Code: HSBCSGSG Bank Code: 7232 • Payment by Credit Card (AMEX, VISA or MasterCard). The best way to pay by credit card is through our secure portal built into the website. To pay by phone please indicate the contact name and details below and our Customer Services Team will call within 24 hours to take payment. Please do not send credit card information by email. SAVE WITH THE EARLY BIRD & SPECIAL RATES! The personal information entered during your registration/order, or provided by you, will be held on a database and may be shared with companies in the Informa Group in the UK and internationally. Occasionally, your details may be obtained from or shared with external companies who wish to communicate with you offers related to your business activities. If you do not wish your details to be used for this purpose, please contact our Database Department at Email: database@ibcasia.com.sg, Tel: +65 6508 2400 or Fax: +65 6508 2408. Should you be unable to attend, a substitute delegate is welcome at no extra charge. Cancellations must be received in writing at least 10 business days before the start of the event, to receive a refund less 10% processing fee per registration. The company regrets that no refund will be made available for cancellation notifications received less than 10 business days before the event. Please quote the name of the delegate, event title and invoice number on the advice when remitting payment. Bank charges are to be deducted from participating organisations own accounts. Please fax your payment details (copy of remittance advice, cheque or draft to +65 6508 2407). Attendance will only be permitted upon receipt of full payment. Participants wishing to register at the door are responsible to ensure all details are as published. IBC assumes no further liability or obligation, beyond the refund of the paid registration fee, in the event of postponement or cancellation by IBC. MAIL the attached registration form with your cheque to IBC Asia (S) Pte Ltd c/o Informa Regional Business Services 111 Somerset Road, TripleOne Somerset #10-06, Singapore 238164 Scan the QR Code with your smartphone and register today Early Bird Rate Register & pay on or before 20 Jun 2014 FEE PER DELEGATE Special Rate Register & pay on or before 18 Jul 2014 Group Rate (3 or more delegates) Normal Rate Register & pay after 18 Jul 2014 ❑ 2 Day Conference only SGD 3,895 SGD 4,095 SGD 4,295 SGD 3,795❑ 4 Day Package: 2 Day Conference + All Workshops SGD 2,595 SGD 2,795 SGD 2,995 SGD 2,495 • Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time. Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR special rate OR group rate. • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel. • Registration fees are subject to the prevailing government tax Who is Head of your Department? Who is Head of Training? Company Information Company Name: Address: Main Business/Activity: Postal Code: Please photocopy for additional delegates FREE GROUPDISCOUNT Delegate 1 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 2 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 3 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: Delegate 4 Details Name: Dr/Mr/Ms Job Title: Department Tel: Mobile No.: Email: ❑ 3 Day Package: 2 Day Conference ❑ Pre-Conference Workshop OR ❑ Post-Conference Workshop SGD 3,295 SGD 3,495 SGD 3,695 SGD 3,195 PARKROYAL on Beach Road 7500 Beach Road, Singapore 199591 Hotel mainline: +65 6505 5666 Contact Person: Teo Hui Ling Tel: +65 6505 5696 Email: teo.huiling@parkroyalhotels.com GROUP BONUS – Register 3 Delegates from the same company and the 4th Delegate attends FREE! ❑ Present a Poster SGD100 for Industry and Free for Academic 4 Successful Events Under 1 Roof 180+ Attendees to Network With 4+ Days of Expert Knowledge Sharing 80+ Expert Pharmaceutical Stakeholders & Key Decision Makers 15+ Interactive Formats to Get To Know Your Peers & Customers 1 Joint Exhibition Area Part of: spex